Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis

References

• Malmström V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017;17(1):60–75.
   PubMed Web of Science ®Google Scholar
• Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 1996;87(5):811–22.
   PubMed Web of Science ®Google Scholar
• Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999;10(4):451–61.
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science. 1999;286(5445):1732–5.
   PubMed Web of Science ®Google Scholar
• Basu D, Horvath S, Matsumoto I, Fremont DH, Allen PM. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J Immunol. 2000;164(11):5788–96.
   PubMed Web of Science ®Google Scholar
• Kyburz D, Carson DA, Corr M. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheum. 2000;43(11):2571–7.
   PubMedGoogle Scholar
• Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol. 2002;3(4):360–5.
   PubMed Web of Science ®Google Scholar
• Wipke BT, Wang Z, Kim J, McCarthy TJ, Allen PM. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat Immunol. 2002;3(4):366–72.
   PubMed Web of Science ®Google Scholar
• Studelska DR, Mandik-Nayak L, Zhou X, Pan J, Weiser P, McDowell LM, et al. High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis. J Biol Chem. 2009;284(4):2354–6.
   PubMed Web of Science ®Google Scholar
• Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001;167(3):1601–8.
   PubMed Web of Science ®Google Scholar
• Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FMA, Boackle SA, et al. Arthritis critically dependent on innate immune system players. Immunity. 2002;16(2):157–68.
   PubMed Web of Science ®Google Scholar
• Monach PA, Nigrovic PA, Chen M, Hock H, Lee DM, Benoist C, et al. Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum. 2010;62(3):753–64.
   PubMedGoogle Scholar
• Tsuboi N, Ernandez T, Li X, Nishi H, Cullere X, Mekala D, et al. Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice. Arthritis Rheum. 2011;63(2):467–78.
   PubMedGoogle Scholar
• Mancardi DA, Jönsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, et al. Cutting edge: the murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J Immunol. 2011;186(4):1899–903.
   PubMed Web of Science ®Google Scholar
• Cremasco V, Graham DB, Novack DV, Swat W, Faccio R. Vav/phospholipase C gamma2-mediated control of a neutrophil-dependent murine model of rheumatoid arthritis. Arthritis Rheum. 2008;58(9):2712–22.
   PubMedGoogle Scholar
• Jakus Z, Simon E, Frommhold D, Sperandio M, Mócsai A. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J Exp Med. 2009;206(3):577–93.
   PubMed Web of Science ®Google Scholar
• Elliott ER, Van Ziffle JA, Scapini P, Sullivan BM, Locksley RM, Lowell CA. Deletion of Syk in neutrophils prevents immune complex arthritis. J Immunol. 2011;187(8):4319–30.
   PubMed Web of Science ®Google Scholar
• Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med. 2006;203(4):837–42.
   PubMed Web of Science ®Google Scholar
• Kim ND, Chou RC, Seung E, Tager AM, Luster AD. A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis. J Exp Med. 2006;203(4):829–35.
   PubMed Web of Science ®Google Scholar
• Chou RC, Kim ND, Sadik CD, Seung E, Lan Y, Byrne MH, et al. Lipid–cytokine–chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity. 2010;33(2):266–78.
   PubMed Web of Science ®Google Scholar
• Chen M, Lam BK, Luster AD, Zarini S, Murphy RC, Bair AM, et al. Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis. J Immunol. 2010;185(9):5503–11.
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Ortiz-Lopez A, Campbell JJ, Gerard CJ, Mathis D, Benoist C. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 2010;62(7):1921–32.
   PubMedGoogle Scholar
• Santos LL, Fan H, Hall P, Ngo D, Mackay CR, Fingerle-Rowson G, et al. Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice. Arthritis Rheum. 2011;63(4):960–70.
   PubMedGoogle Scholar
• Wu HJ, Sawaya H, Binstadt B, Brickelmaier M, Blasius A, Gorelik L, et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med. 2007;204(8):1911–22.
   PubMed Web of Science ®Google Scholar
• Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002;297(5587):1689–92.
   PubMed Web of Science ®Google Scholar
• Kneilling M, Hültner L, Pichler BJ, Mailhammer R, Morawietz L, Solomon S, et al. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 2007;56(6):1806–16.
   PubMedGoogle Scholar
• Nigrovic PA, Binstadt BA, Monach PA, Johnsen A, Gurish M, Iwakura Y, et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA. 2007;104(7):2325–30.
   PubMed Web of Science ®Google Scholar
• Nigrovic PA, Malbec O, Lu B, Markiewski MM, Kepley C, Gerard N, et al. C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulation. Arthritis Rheum. 2010;62(11):3322–33.
   PubMedGoogle Scholar
• Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS, et al. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol. 2009;182(1):647–56.
   PubMed Web of Science ®Google Scholar
• Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper SB, Illges H. A crucial role for macrophages in the pathology of K/B × N serum-induced arthritis. Eur J Immunol. 2005;35(10):3064–73.
   PubMed Web of Science ®Google Scholar
• Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity. 2003;18(4):573–81.
   PubMed Web of Science ®Google Scholar
• Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med. 2002;196(1):77–85.
   PubMed Web of Science ®Google Scholar
• Choe JY, Crain B, Wu SR, Corr M. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med. 2003;197(4):537–42.
   PubMed Web of Science ®Google Scholar
• Jacobs JP, Wu HJ, Benoist C, Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci USA. 2009;106(51):21789–94.
   PubMed Web of Science ®Google Scholar
• Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815–27.
   PubMed Web of Science ®Google Scholar
• Sadik CD, Kim ND, Alekseeva E, Luster AD. IL-17RA signaling amplifies antibody-induced arthritis. PLoS One. 2011;6(10):e26342.
   PubMed Web of Science ®Google Scholar
• Katayama M, Ohmura K, Yukawa N, Terao C, Hashimoto M, Yoshifuji H, et al. Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. PLoS One. 2013;8(5):e62231.
   PubMed Web of Science ®Google Scholar
• Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol. 2004;172(12):7694–702.
   PubMed Web of Science ®Google Scholar
• Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol. 2006;7(3):284–92.
   PubMed Web of Science ®Google Scholar
• Schubert D, Maier B, Morawietz L, Krenn V, Kamradt T. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol. 2004;172(7):4503–9.
   PubMed Web of Science ®Google Scholar
• Bockermann R, Schubert D, Kamradt T, Holmdahl R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther. 2005;7(6):R1316–24.
   PubMed Web of Science ®Google Scholar
• Tanaka-Watanabe Y, Matsumoto I, Iwanami K, Inoue A, Goto D, Ito S, et al. B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis. Clin Exp Immunol. 2009;155(2):285–94.
   PubMed Web of Science ®Google Scholar
• Frey O, Bruns L, Morawietz L, Dunussi-Joannopoulos K, Kamradt T. B cell depletion reduces the number of autoreactive T helper cells and prevents glucose-6-phosphate isomerase-induced arthritis. PLoS One. 2011;6(9):e24718.
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, et al. Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis. Arthritis Res Ther. 2008;10(3):R66.
   PubMed Web of Science ®Google Scholar
• Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum. 2008;58(3):754–63.
   PubMed Web of Science ®Google Scholar
• Frey O, Meisel J, Hutloff A, Bonhagen K, Bruns L, Kroczek RA, et al. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann Rheum Dis. 2010;69(8):1495–501.
   PubMed Web of Science ®Google Scholar
• Ishiguro A, Akiyama T, Adachi H, Inoue J, Nakamura Y. Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models. Arthritis Rheum. 2011;63(2):455–66.
   PubMedGoogle Scholar
• Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997;158(11):5507–13.
   PubMed Web of Science ®Google Scholar
• Frey O, Mitera T, Kelchtermans H, Schurgers E, Kamradt T, Matthys P. Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-γ receptor knockout mice exposes an arthritis-promoting role of IFN-γ. J Autoimmun. 2011;36(2):161–9.
   PubMed Web of Science ®Google Scholar
• Frey O, Reichel A, Bonhagen K, Morawietz L, Rauchhaus U, Kamradt T. Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis. Ann Rheum Dis. 2010;69(8):1511–8.
   PubMed Web of Science ®Google Scholar
• Iwanami K, Matsumoto I, Tanaka Y, Inoue A, Goto D, Ito S, et al. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis. Arthritis Res Ther. 2008;10(6):R130.
   PubMed Web of Science ®Google Scholar
• Bruns L, Frey O, Morawietz L, Landgraf C, Volkmer R, Kamradt T. Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice. Arthritis Res Ther. 2009;11(4):R117.
   PubMed Web of Science ®Google Scholar
• Pizzolla A, Wing K, Holmdahl R. A glucose-6-phosphate isomerase peptide induces T and B cell-dependent chronic arthritis in C57BL/10 mice: arthritis without reactive oxygen species and complement. Am J Pathol. 2013;183(4):1144–55.
   PubMed Web of Science ®Google Scholar
• Llop-Guevara A, Porras M, Cendón C, Di Ceglie I, Siracusa F, Madarena F, et al. Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice. Arthritis Res Ther. 2015;17(1):356.
   PubMedGoogle Scholar
• Iwanami K, Matsumoto I, Yoshiga Y, Inoue A, Kondo Y, Yamamoto K, et al. Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide. Arthritis Res Ther. 2009;11(6):R167.
   PubMed Web of Science ®Google Scholar
• Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, et al. Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase. Mod Rheumatol. 2017;27(3):457–65.
   PubMed Web of Science ®Google Scholar
• Akashi N, Matsumoto I, Tanaka Y, Inoue A, Yamamoto K, Umeda N, et al. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis. Mod Rheumatol. 2011;21(3):267–75.
   PubMed Web of Science ®Google Scholar
• Horikoshi M, Goto D, Segawa S, Yoshiga Y, Iwanami K, Inoue A, et al. Activation of invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis. PLoS One. 2012;7(12):e51215.
   PubMed Web of Science ®Google Scholar
• Chen Q, Muramoto K, Masaaki N, Ding Y, Yang H, Mackey M, et al. A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br J Pharmacol. 2010;160(2):292–310.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, et al. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interlukin-6. Mod Rheumatol. 2018:1–16. in press.
   PubMed Web of Science ®Google Scholar
• Inoue A, Matsumoto I, Tanaka Y, Iwanami K, Kanamori A, Ochiai N, et al. Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis. Arthritis Res Ther. 2009;11(4):R118.
   PubMed Web of Science ®Google Scholar
• Inoue A, Matsumoto I, Tanaka Y, Umeda N, Tanaka Y, Mihara M, et al. Murine tumor necrosis factor α-induced adipose-related protein (tumor necrosis factor α-induced protein 9) deficiency leads to arthritis via interleukin-6 overproduction with enhanced NF-κB, STAT-3 signaling, and dysregulated apoptosis of macrophages. Arthritis Rheum. 2012;64(12):3877–85.
   PubMedGoogle Scholar
• Kawaguchi H, Matsumoto I, Osada A, Kurata I, Ebe H, Tanaka Y, et al. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):66.
   PubMed Web of Science ®Google Scholar
• Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, et al. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci Rep. 2015;21(5):13041.
   Google Scholar
• Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001;2(8):746–53.
   PubMed Web of Science ®Google Scholar
• Schaller M, Stohl W, Tan SM, Benoit VM, Hilbert DM, Ditzel HJ. Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Ann Rheum Dis. 2005;64(5):743–9.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lee MH, Jung KI, Na HY, Cha HS, Ko EM, et al. Detection of antibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance (BIAcore). Exp Mol Med. 2003;35(4):310–6.
   PubMed Web of Science ®Google Scholar
• Cha HS, Kim TJ, Kim JY, Lee MH, Jeon CH, Kim J, et al. Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients. Scand J Rheumatol. 2004;33(3):179–84.
   PubMed Web of Science ®Google Scholar
• Schaller M, Stohl W, Benoit V, Tan SM, Johansen L, Ditzel HJ. Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochem Biophys Res Commun. 2006;349(2):838–45.
   PubMed Web of Science ®Google Scholar
• Schubert D, Schmidt M, Zaiss D, Jungblut PR, Kamradt T. Autoantibodies to GPI and creatine kinase in RA. Nat Immunol. 2002;3(5):411.
   PubMed Web of Science ®Google Scholar
• Kassahn D, Kolb C, Solomon S, Bochtler P, Illges H. Few human autoimmune sera detect GPI. Nat Immunol. 2002;3(5):411–2.
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Lee DM, Goldbach-Mansky R, Sumida T, Hitchon CA, Schur PH, et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 2003;48(4):944–54.
   PubMedGoogle Scholar
• Herve CA, Wait R, Venables PJ. Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology (Oxford). 2003;42(8):986–8.
   PubMed Web of Science ®Google Scholar
• Schepp CP, Dannecker L, Haug M, Kümmerle-Deschner J, Beck H, Kötter I, et al. Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target. J Rheumatol. 2004;31(8):1630–8.
   PubMed Web of Science ®Google Scholar
• Jouen F, Vittecoq O, Leguillou F, Tabti-Titon I, Menard JF, Mejjad O, et al. Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis. Clin Exp Immunol. 2004;137(3):606–11.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Matsumoto I, Muraki Y, Takahashi R, Chino Y, Goto D, et al. Clinical characteristics of anti-glucose-6-phosphate isomerase antibodies positive Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2005;15(4):258–63.
   PubMedGoogle Scholar
• van Gaalen FA, Toes RE, Ditzel HJ, Schaller M, Breedveld FC, Verweij CL, et al. Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum. 2004;50(2):395–9.
   PubMedGoogle Scholar
• Petkova SB, Konstantinov KN, Sproule TJ, Lyons BL, Awwami MA, Roopenian DC. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIIB. J Exp Med. 2006;203(2):275–80.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Muraki Y, Yasukochi T, Zhang H, Kori Y, Wakamatsu E, et al. Immunoglobulin G from anti-glucose-6-phosphate isomerase antibodies positive patient with rheumatoid arthritis induces synovitis in cynomolgus monkeys. Autoimmun Rev. 2005;4(7):475–8.
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Zhang H, Muraki Y, Hayashi T, Yasukochi T, Kori Y, et al. A functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies. Arthritis Res Ther. 2005;7(6):R1183.
   PubMed Web of Science ®Google Scholar
• Furuya T, Matsumoto I, Tsuchiya N, Hakoda M, Ichikawa N, Yago T, et al. Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis. Clin Exp Rheumatol. 2008;26(5):918–21.
   PubMed Web of Science ®Google Scholar
• Kori Y, Matsumoto I, Zhang H, Yasukochi T, Hayashi T, Iwanami K, et al. Characterisation of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis. Ann Rheum Dis. 2005;65(7):968–9.
   Web of Science ®Google Scholar
• Dai L, Zhu LJ, Zheng DH, Mo YQ, Wei XN, Su JH, et al. Elevated serum glucose-6-phosphate isomerase correlates with histological disease activity and clinical improvement after initiation of therapy in patients with rheumatoid arthritis. J Rheumatol. 2010;37(12):2452–61.
   PubMed Web of Science ®Google Scholar
• Fan LY, Zong M, Wang Q, Yang L, Sun LS, Ye Q, et al. Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis. Clin Chim Acta. 2010;411(23–24):2049–53.
   PubMed Web of Science ®Google Scholar
• Umeda N, Matsumoto I, Ito I, Kawasaki A, Tanaka Y, Inoue A, et al. Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity. Clin Exp Immunol. 2013;172(1):44–53.
   PubMed Web of Science ®Google Scholar
• Umeda N, Matsumoto I, Tanaka Y, Kawaguchi H, Ebe H, Kagami Y, et al. Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide-7 (CCG-7) antibodies were suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in the RA synovium. Mod Rheumatol. 2017;27(5):914–6.
   PubMed Web of Science ®Google Scholar
• Titcombe PJ, Wigerblad G, Sippl N, Zhang N, Shmagel AK, Sahlström P, et al. Pathogenic citrulline-multispecific B cell receptor clades in rheumatoid arthritis. Arthritis Rheumatol. 2018;70(12):1933–45.
   PubMed Web of Science ®Google Scholar
• Inoue A, Matsumoto I, Tanaka Y, Umeda N, Takai C, Kawaguchi H, et al. TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression. Sci Rep. 2016;6(1):38684.
   PubMedGoogle Scholar
• Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, et al. Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2012;30(1):99–102.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Minami R, Umeda N, et al. Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is TNFalpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis. Mod Rheumatol. 2012;22(1):128–36.
   PubMed Web of Science ®Google Scholar
• Takai C, Matsumoto I, Inoue A, Umeda N, Tanaka Y, Kurashima Y, et al. Specific overexpression of TNFAIP9 in CD14 + CD16– monocytes in patients with rheumatoid arthritis- Comparative analysis with TNFAIP3. Clin Exp Immunol. 2015;180(3):458–66.
   PubMed Web of Science ®Google Scholar
• Ebe H, Matsumoto I, Kawaguchi H, Kurata I, Tanaka Y, Inoue A, et al. Clinical and functional significance of STEAP4-splice variant in CD14+ monocytes in patients with rheumatoid arthritis. Clin Exp Immunol. 2018;191(3):338–48.
   PubMed Web of Science ®Google Scholar
• Ebe H, Matsumoto I, Osada A, Kurata I, Kawaguchi H, Kondo Y, et al. Splice variant of STEAP4 localizes in the nucleus, making it a possible transcriptional regulator of IL-6 production. Mod Rheumatol. 2019;29(4):714–6.
   PubMed Web of Science ®Google Scholar
• Grunewald TG, Bach H, Cossarizza A, Matsumoto I. The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. Biol Cell. 2012;104(11):641–57.
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Inoue A, Takai C, Umeda N, Tanaka Y, Kurashima Y, et al. Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIP) 3 and 9 in arthritis. Clin Immunol. 2014;153(1):73–8.
   PubMed Web of Science ®Google Scholar